Clinical Trial Update: A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma [Phase 2]

View source ↗

Summary

A Phase II pediatric trial assessing lung function in children aged 4 to <12 with asthma, comparing two doses of inhaled glycopyrronium added to budesonide/form…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol (budesonide/formoterol)
• glycopyrronium (glycopyrronium)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: RECRUITING